Assessment of glycated Hemoglobin using AlCNow+™ point-of-care device as compared to central laboratory testing

Journal of Diabetes Science and Technology

Volumn 2, Issue 5, 2008, Pages 822-827

  Arrendale, Justin R ^a,b   Cherian, Sonia E ^c   Zineh, Issam ^d   Chirico, Mark J ^d   Taylor, James R ^d  

^a MORRISTOWN MEMORIAL HOSPITAL   (United States)

^b LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^c PALM BEACH ATLANTIC UNIVERSITY   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Diabetes; Hemoglobin Alc; Point of care

Indexed keywords

EID: 81255205031     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200512     Document Type: Article

References (11)

1. American Diabetes Association [accessed 2008 Mar. 12]. Available from: www.diabetes.org.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352(9131):837-53.
4. Thaler LM, Ziemer DC, Gallina DL, Cook CB, Dunbar VG, Phillips LS, El-Kebbi IM. Diabetes in urban African-Americans. XVII. Availability of rapid HbAlc measurements enhances clinical decision making. Diabetes Care. 1999;22(9):1415-21.
5. Marrero DG, Kraft S, Fineberg N. Effect of immediate feedback of HbAlc on patient glycemic control and physicians' treatment decisions [abstract]. Diabetes. 1996;45:7A.
6. Cagliero E, Levina E, Nathan DM. Immediate feedback of HbAlc levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care. 1999;22(11):1785-88.
7. Sicard DA, Taylor JR. Comparison of point-of-care HbAlc test versus standardized laboratory. Ann Pharmacother. 2005;39(6):1024-28.
8. National Glycohemoglobin Standardization Program [accessed 2007 Sep. 12]. Available from: www.ngsp.org.
9. Kennedy L, Herman WH; GOAL A1C Study Team. Glycated hemoglobin assessment in clinical practice: comparison of the AlcNow point-of-care device with central laboratory testing (GOAL A1C Study). Diabetes Technol Ther. 2005;7(6):907-12.
10. Metrika Incorporated. AlCNow+ package insert. Sunnyvale, CA: Metrika; 2006.
11. Metrika Incorporated [accessed 2008 Mar. 7]. Available from: www.metrika.com.